Top-Rated StocksTop-RatedNASDAQ:RCM R1 RCM (RCM) Stock Forecast, Price & News $14.37 -0.58 (-3.88%) (As of 01:27 PM ET) Add Compare Share Share Today's Range$14.37▼$14.8550-Day Range$14.95▼$18.2252-Week Range$6.71▼$19.46Volume775,237 shsAverage Volume2.50 million shsMarket Capitalization$6.02 billionP/E RatioN/ADividend YieldN/APrice Target$19.11 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability R1 RCM MarketRank™ ForecastAnalyst RatingModerate Buy2.88 Rating ScoreUpside/Downside29.5% Upside$19.11 Price TargetShort InterestBearish8.35% of Float Sold ShortDividend StrengthN/ASustainability-1.33Upright™ Environmental ScoreNews Sentiment1.31Based on 5 Articles This WeekInsider TradingSelling Shares$858,500 Sold Last QuarterProj. Earnings Growth233.33%From $0.09 to $0.30 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.94 out of 5 starsBusiness Services Sector24th out of 319 stocksManagement Services Industry2nd out of 5 stocks 4.4 Analyst's Opinion Consensus RatingR1 RCM has received a consensus rating of Moderate Buy. The company's average rating score is 2.88, and is based on 14 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $19.11, R1 RCM has a forecasted upside of 29.5% from its current price of $14.75.Amount of Analyst CoverageR1 RCM has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 1.0 Short Interest Percentage of Shares Shorted8.35% of the float of R1 RCM has been sold short.Short Interest Ratio / Days to CoverR1 RCM has a short interest ratio ("days to cover") of 7.3.Change versus previous monthShort interest in R1 RCM has recently increased by 6.08%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldR1 RCM does not currently pay a dividend.Dividend GrowthR1 RCM does not have a long track record of dividend growth. Previous Next 3.6 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreR1 RCM has received a 45.11% net impact score from Upright. R1 Rcm seems to create the most significant positive value in categories "Jobs", "Taxes", and "Physical diseases". The positive contribution in the "Physical diseases" impact category is mostly driven by its "Documentation software for clinicians", "Personal health record software", and "Hospital cost management software" products. See details.Environmental SustainabilityThe Environmental Impact score for R1 RCM is -1.33. Previous Next 3.5 News and Social Media Coverage News SentimentR1 RCM has a news sentiment score of 1.31. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Business Services companies.News Coverage This WeekMarketBeat has tracked 5 news articles for R1 RCM this week, compared to 4 articles on an average week.MarketBeat Follows2 people have added R1 RCM to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, R1 RCM insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $858,500.00 in company stock.Percentage Held by Insiders37.00% of the stock of R1 RCM is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions61.10% of the stock of R1 RCM is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for R1 RCM are expected to grow by 233.33% in the coming year, from $0.09 to $0.30 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of R1 RCM is -92.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of R1 RCM is -92.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioR1 RCM has a P/B Ratio of 2.26. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About R1 RCM (NASDAQ:RCM) StockR1 RCM Inc. provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and physician groups. It offers end-to-end revenue cycle management (RCM) services, which address the spectrum of revenue cycle challenges faced by healthcare providers. The company provides modular services, including physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. R1 RCM Inc. was founded in 2003 and is headquartered in Murray, Utah.Read More RCM Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RCM Stock News HeadlinesSeptember 26, 2023 | finance.yahoo.comAssessing the True Worth of R1 RCM (RCM): A Comprehensive Guide to its ValuationSeptember 26, 2023 | finance.yahoo.comUnraveling the Future of R1 RCM Inc (RCM): A Deep Dive into Key MetricsOctober 3, 2023 | Chaikin Analytics (Ad)Buy This Stock for AI Tidal Wave (not NVDA)The internet boom made more millionaires than any tech - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.September 24, 2023 | americanbankingnews.comR1 RCM (NASDAQ:RCM) Now Covered by CitigroupSeptember 24, 2023 | americanbankingnews.comR1 RCM (NASDAQ:RCM) Rating Reiterated by Royal Bank of CanadaSeptember 23, 2023 | americanbankingnews.comR1 RCM Inc. (NASDAQ:RCM) Given Average Recommendation of "Moderate Buy" by AnalystsSeptember 20, 2023 | finance.yahoo.comR1 RCM Inc. sees growth despite trading at discountSeptember 18, 2023 | finance.yahoo.comReturns On Capital Are Showing Encouraging Signs At R1 RCM (NASDAQ:RCM)October 3, 2023 | Chaikin Analytics (Ad)Buy This Stock for AI Tidal Wave (not NVDA)The internet boom made more millionaires than any tech - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.September 12, 2023 | finance.yahoo.comImplied Volatility Surging for R1 RCM (RCM) Stock OptionsAugust 27, 2023 | msn.comR1 RCM: Attractively Priced, Capital Produces $0.90/Share In Earnings, Reiterate BuyAugust 20, 2023 | finance.yahoo.comOne R1 RCM Insider Raised Their Stake In The Previous YearAugust 15, 2023 | msn.comCantor Fitzgerald Initiates Coverage of R1 RCM (RCM) with Overweight RecommendationAugust 15, 2023 | markets.businessinsider.comR1 RCM's Robust Client Base And $1.2 Trillion Potential: The Growth Forecast By AnalystAugust 7, 2023 | markets.businessinsider.comTruist Financial Sticks to Its Hold Rating for R1 RCM (RCM)August 5, 2023 | markets.businessinsider.comRBC Capital Reaffirms Their Buy Rating on R1 RCM (RCM)August 4, 2023 | markets.businessinsider.comRobert W. Baird Keeps Their Buy Rating on R1 RCM (RCM)August 3, 2023 | msn.comBarclays Maintains R1 RCM (RCM) Overweight RecommendationAugust 2, 2023 | finance.yahoo.comR1 RCM Inc. (RCM) Reports Break-Even Earnings for Q2August 2, 2023 | finance.yahoo.comCompared to Estimates, R1 RCM Inc. (RCM) Q2 Earnings: A Look at Key MetricsAugust 2, 2023 | seekingalpha.comR1 RCM Inc. 2023 Q2 - Results - Earnings Call PresentationAugust 2, 2023 | finanznachrichten.deR1 RCM Inc.: R1 RCM Reports Second Quarter 2023 ResultsAugust 2, 2023 | finance.yahoo.comR1 RCM Reports Second Quarter 2023 ResultsAugust 1, 2023 | seekingalpha.comR1 RCM Q2 2023 Earnings PreviewJuly 21, 2023 | msn.comGuggenheim Reiterates R1 RCM (RCM) Buy RecommendationJuly 21, 2023 | markets.businessinsider.com6 Analysts Have This to Say About R1 RCMJuly 19, 2023 | markets.businessinsider.comTruist Financial Keeps Their Hold Rating on R1 RCM (RCM)See More Headlines Receive RCM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for R1 RCM and its competitors with MarketBeat's FREE daily newsletter. Email Address RCM Company Calendar Last Earnings2/16/2023Today10/03/2023Next Earnings (Estimated)11/14/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Management services Sub-IndustryHealth Care Services SectorBusiness Services Current SymbolNASDAQ:RCM Previous SymbolNYSE:RCM CUSIP00438V10 CIK1472595 Webwww.r1rcm.com Phone(312) 324-7820Fax302-655-5049Employees27,800Year Founded2003Price Target and Rating Average Stock Price Forecast$19.11 High Stock Price Forecast$25.00 Low Stock Price Forecast$10.00 Forecasted Upside/Downside+27.8%Consensus RatingModerate Buy Rating Score (0-4)2.88 Research Coverage16 Analysts Profitability EPS (Most Recent Fiscal Year)($0.16) Trailing P/E RatioN/A Forward P/E Ratio166.11 P/E GrowthN/ANet Income$-57,600,000.00 Net Margins-3.09% Pretax Margin-2.82% Return on Equity-2.41% Return on Assets-1.30% Debt Debt-to-Equity Ratio0.62 Current Ratio1.80 Quick Ratio1.80 Sales & Book Value Annual Sales$1.81 billion Price / Sales3.47 Cash Flow$0.28 per share Price / Cash Flow53.19 Book Value$6.53 per share Price / Book2.29Miscellaneous Outstanding Shares418,960,000Free Float263,944,000Market Cap$6.26 billion OptionableNot Optionable Beta0.87 Social Links 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. Lee Rivas (Age 48)CEO & Director Comp: $1.12MMr. John M. Sparby (Age 47)Pres Comp: $656.99kMs. Jennifer Williams (Age 46)Exec. VP, CFO & Treasurer Mr. Richard B. Evans Jr. (Age 55)Sr. VP, Corp. Controller & Chief Accounting Officer Mr. Atif A. RahimSr. VP of Investor Relations & Bus. Devel.Mr. Corey PermanExec. VP of Compliance & RiskMr. Sean RadcliffeExec. VP, Gen. Counsel & Corp. Sec.Ms. Kate SandersonExec. VP & Chief HR OfficerMr. David StrickleExec. VP of IntegrationMr. Kyle A. Hicok (Age 43)Exec. VP & Chief Commercial Officer More ExecutivesKey CompetitorsSPS CommerceNASDAQ:SPSCCore & MainNYSE:CNMDuolingoNYSE:DUOLGenpactNYSE:GFTI ConsultingNYSE:FCNView All CompetitorsInsiders & InstitutionsBarclays PLCSold 78,505 shares on 9/21/2023Ownership: 0.059%California State Teachers Retirement SystemBought 14,502 shares on 8/21/2023Ownership: 0.047%Teachers Retirement System of The State of KentuckyBought 2,262 shares on 8/21/2023Ownership: 0.005%Osaic Holdings Inc.Sold 1,156 shares on 8/21/2023Ownership: 0.001%Lazard Asset Management LLCBought 4,387 shares on 8/15/2023Ownership: 0.001%View All Insider TransactionsView All Institutional Transactions RCM Stock - Frequently Asked Questions Should I buy or sell R1 RCM stock right now? 16 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for R1 RCM in the last year. There are currently 2 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" RCM shares. View RCM analyst ratings or view top-rated stocks. What is R1 RCM's stock price forecast for 2023? 16 Wall Street analysts have issued twelve-month target prices for R1 RCM's stock. Their RCM share price forecasts range from $10.00 to $25.00. On average, they predict the company's stock price to reach $19.11 in the next year. This suggests a possible upside of 27.8% from the stock's current price. View analysts price targets for RCM or view top-rated stocks among Wall Street analysts. How have RCM shares performed in 2023? R1 RCM's stock was trading at $10.95 at the beginning of 2023. Since then, RCM stock has increased by 36.5% and is now trading at $14.95. View the best growth stocks for 2023 here. When is R1 RCM's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023. View our RCM earnings forecast. How were R1 RCM's earnings last quarter? R1 RCM Inc. (NASDAQ:RCM) issued its quarterly earnings results on Thursday, February, 16th. The healthcare provider reported ($0.09) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.03) by $0.06. The healthcare provider earned $532.80 million during the quarter, compared to the consensus estimate of $519.28 million. R1 RCM had a negative net margin of 3.09% and a negative trailing twelve-month return on equity of 2.41%. The company's revenue was up 33.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.11 EPS. What ETFs hold R1 RCM's stock? ETFs with the largest weight of R1 RCM (NASDAQ:RCM) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Thrivent Small-Mid Cap ESG ETF (TSME), Fidelity Digital Health ETF (FDHT), SPDR S&P Health Care Services ETF (XHS) and iShares U.S. Healthcare Providers ETF (IHF).Invesco NASDAQ Next Gen 100 ETF (QQQJ). What guidance has R1 RCM issued on next quarter's earnings? R1 RCM updated its FY 2023 earnings guidance on Wednesday, August, 2nd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $2.25 billion-$2.27 billion, compared to the consensus revenue estimate of $2.31 billion. What is Joseph Flanagan's approval rating as R1 RCM's CEO? 253 employees have rated R1 RCM Chief Executive Officer Joseph Flanagan on Glassdoor.com. Joseph Flanagan has an approval rating of 70% among the company's employees. What other stocks do shareholders of R1 RCM own? Based on aggregate information from My MarketBeat watchlists, some companies that other R1 RCM investors own include NVIDIA (NVDA), JD.com (JD), Baozun (BZUN), Inseego (INSG), BioXcel Therapeutics (BTAI), Marvell Technology (MRVL), Akoustis Technologies (AKTS), Alibaba Group (BABA), Bilibili (BILI) and Model N (MODN). What is R1 RCM's stock symbol? R1 RCM trades on the NASDAQ under the ticker symbol "RCM." How do I buy shares of R1 RCM? Shares of RCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is R1 RCM's stock price today? One share of RCM stock can currently be purchased for approximately $14.95. How much money does R1 RCM make? R1 RCM (NASDAQ:RCM) has a market capitalization of $6.26 billion and generates $1.81 billion in revenue each year. The healthcare provider earns $-57,600,000.00 in net income (profit) each year or ($0.16) on an earnings per share basis. How many employees does R1 RCM have? The company employs 27,800 workers across the globe. Does R1 RCM have any subsidiaries? The following companies are subsidiares of R1 RCM: Accretive Health Mauritius Inc., Cerner RevWorks, Clearsight Intermediate Holdings Inc., Cloudmed, Flare Capital Partners Investment Company, Intermedix, Intermedix ARM LLC, Intermedix Corporation, Intermedix Holdings Inc., Intermedix Lietuva UAB, Intermedix Midco Inc., Intermedix Office Based LLC, Intermedix Staffing Inc., Medical Consultants Inc., Practice Support Resources LLC, Project Links Parent Inc., Project Roadrunner Merger Sub Inc., Project Roadrunner Parent Inc., R1 RCM Global Private Limited, R1 RCM India Private Limited, Rover16 Inc., SCHEDULING.COM INC., SCI Solutions, Tonic Health LLC, VisitPay, cGate Health Inc., and iVinci Partners LLC.Read More How can I contact R1 RCM? R1 RCM's mailing address is 401 NORTH MICHIGAN AVENUE SUITE 2700, CHICAGO IL, 60611. The official website for the company is www.r1rcm.com. The healthcare provider can be reached via phone at (312) 324-7820, via email at arahim@r1rcm.com, or via fax at 302-655-5049. This page (NASDAQ:RCM) was last updated on 10/3/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding R1 RCM Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.